CLYM logo

CLYM
Climb Bio Inc.

343
Mkt Cap
$384.53M
Volume
828,039.00
52W High
$8.52
52W Low
$1.13
PE Ratio
-9.49
CLYM Fundamentals
Price
$8.41
Prev Close
$8.05
Open
$8.10
50D MA
$6.47
Beta
1.11
Avg. Volume
508,247.54
EPS (Annual)
-$0.8826
P/B
2.50
Rev/Employee
$0.00
$170.71
Loading...
Loading...
News
all
press releases
Climb Bio's (CLYM) "Buy" Rating Reaffirmed at BTIG Research
BTIG Research reissued a "buy" rating and issued a $8.00 price objective on shares of Climb Bio in a research report on Wednesday...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Climb Bio, Inc. (NASDAQ:CLYM) Receives Consensus Recommendation of "Buy" from Analysts
Shares of Climb Bio, Inc. (NASDAQ:CLYM - Get Free Report) have earned an average rating of "Buy" from the eleven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, seven have issued a buy rating and three have issued a strong buy rati...
MarketBeat·14d ago
News Placeholder
Climb Bio (NASDAQ:CLYM) Raised to Strong-Buy at B. Riley Financial
B. Riley Financial raised Climb Bio to a "strong-buy" rating in a research report on Monday...
MarketBeat·16d ago
News Placeholder
B. Riley Financial Initiates Coverage on Climb Bio (NASDAQ:CLYM)
B. Riley Financial started coverage on Climb Bio in a research report on Tuesday. They set a "buy" rating and a $26.00 target price on the stock...
MarketBeat·18d ago
News Placeholder
Climb Bio (CLYM) Expected to Announce Quarterly Earnings on Tuesday
Climb Bio (NASDAQ:CLYM) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 24. (View Earnings Report at...
MarketBeat·25d ago
News Placeholder
Climb Bio Highlights Budoprutug and CLYM116 Milestones, Sets Up Rich Data Year in 2026
Climb Bio (NASDAQ:CLYM) used a presentation at the Leerink Partners Global Healthcare Conference to outline its strategy around two immune-focused programs and to preview a series of data readouts...
MarketBeat·28d ago
News Placeholder
What is HC Wainwright's Forecast for Climb Bio Q1 Earnings?
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - Investment analysts at HC Wainwright decreased their Q1 2026 earnings per share estimates for shares of Climb Bio in a report issued on Tuesday, March...
MarketBeat·30d ago
News Placeholder
Climb Bio (NASDAQ:CLYM) Shares Gap Up Following Analyst Upgrade
Climb Bio (NASDAQ:CLYM) Shares Gap Up on Analyst Upgrade...
MarketBeat·1mo ago
News Placeholder
Q1 Earnings Forecast for Climb Bio Issued By HC Wainwright
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - HC Wainwright issued their Q1 2027 earnings estimates for Climb Bio in a report issued on Tuesday, March 10th. HC Wainwright analyst R. Selvaraju...
MarketBeat·1mo ago
News Placeholder
Climb Bio (NASDAQ:CLYM) Hits New 52-Week High After Analyst Upgrade
Climb Bio (NASDAQ:CLYM) Sets New 52-Week High After Analyst Upgrade...
MarketBeat·1mo ago
<
1
2
...
>

Latest CLYM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.